Predicting Treatment of Bioprosthetic Aortic Valve Failure in the United States: A Proposed Model
{{output}}
•Transcatheter aortic valve replacement (TAVR) is the dominant treatment for aortic stenosis; the need to treat TAVR failure is increasing.•TAVR valve-in-valve (ViV) is predicted to reach ∼42,000 procedures by 2035.•TAVR ViV will represent ∼15% of all TAV... ...
